MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
DiaTech Oncology
Parents
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Industry: Tennessee
Venture Capital: Angel, Seed & Incubator Series
Children
Amt: 1.20M, Round: Seed/VC
Brentwood, Tennessee
Clinical pathology lab that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for patients.
DiaTech uses a technology called the Microculture Kinetic (MiCK) assay®, which measures apoptosis (cell death) induced in a specific patient's cancer cells by chemotherapy.
Investor(s) Council Capital, PureTech Ventures